Sfoglia per Rivista
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis
2016-01-01 Arbitrio, M; Di Martino, Mt; Barbieri, V; Agapito, G; Botta, C; Iuliano, E; Scionti, F; Altomare, E; Codispoti, S; Conforti, S; Tassone, P; Tagliaferri, P; Cannataro, M; Guzzi, P
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group
2005-01-01 Judson, I; Ma, P; Peng, B; Verweij, J; Racine, A; DONATO DI PAOLA, E; VAN GLABBEKE, M; Dimitrijevic, S; Scurr, M; Dumez, H; VAN OOSTEROM, A
In vivo Activity of Gemcitabine-loaded PEGylated Small Unilamellar Liposomes against Pancreatic Cancer
2009-01-01 Cosco, D; Bulotta, A; Ventura, M; Celia, C; Calimeri, T; Perri, G; Costa, N; Neri, P; Paolino, D; Tassone, P; Tagliaferri, P; Fresta, M
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women >= 65 years of age
2008-01-01 Addeo, R; Faiola, V; Guarrasi, R; Montella, L; Vincenzi, B; Capasso, E; Cennamo, G; Rotundo, Ms; Tagliaferri, P; Caraglia, M; Del Prete, S
Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants
2011-01-01 D' ANGELO, V; Ramaglia, M; Iannotta, A; Crisci, S; Indolfi, P; Francese, M; Affinita, Mc; Pecoraro, G; Napolitano, A; Fusco, C; Oreste, M; Indolfi, C
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
2006-01-01 Caraglia, M; Addeo, R; Costanzo, R; Montella, L; Faiola, V; Marra, M; Abbruzzese, A; Palmieri, G; Budillon, A; Grillone, F; Venuta, S; Tagliaferri, P; Del Prete, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis | 1-gen-2016 | Arbitrio, M; Di Martino, Mt; Barbieri, V; Agapito, G; Botta, C; Iuliano, E; Scionti, F; Altomare, E; Codispoti, S; Conforti, S; Tassone, P; Tagliaferri, P; Cannataro, M; Guzzi, P | |
| Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group | 1-gen-2005 | Judson, I; Ma, P; Peng, B; Verweij, J; Racine, A; DONATO DI PAOLA, E; VAN GLABBEKE, M; Dimitrijevic, S; Scurr, M; Dumez, H; VAN OOSTEROM, A | |
| In vivo Activity of Gemcitabine-loaded PEGylated Small Unilamellar Liposomes against Pancreatic Cancer | 1-gen-2009 | Cosco, D; Bulotta, A; Ventura, M; Celia, C; Calimeri, T; Perri, G; Costa, N; Neri, P; Paolino, D; Tassone, P; Tagliaferri, P; Fresta, M | |
| Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women >= 65 years of age | 1-gen-2008 | Addeo, R; Faiola, V; Guarrasi, R; Montella, L; Vincenzi, B; Capasso, E; Cennamo, G; Rotundo, Ms; Tagliaferri, P; Caraglia, M; Del Prete, S | |
| Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants | 1-gen-2011 | D' ANGELO, V; Ramaglia, M; Iannotta, A; Crisci, S; Indolfi, P; Francese, M; Affinita, Mc; Pecoraro, G; Napolitano, A; Fusco, C; Oreste, M; Indolfi, C | |
| Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours | 1-gen-2006 | Caraglia, M; Addeo, R; Costanzo, R; Montella, L; Faiola, V; Marra, M; Abbruzzese, A; Palmieri, G; Budillon, A; Grillone, F; Venuta, S; Tagliaferri, P; Del Prete, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile